1. Home
  2. AREN vs ABEO Comparison

AREN vs ABEO Comparison

Compare AREN & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • ABEO
  • Stock Information
  • Founded
  • AREN 2016
  • ABEO 1974
  • Country
  • AREN United States
  • ABEO United States
  • Employees
  • AREN N/A
  • ABEO N/A
  • Industry
  • AREN Medical/Dental Instruments
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • ABEO Health Care
  • Exchange
  • AREN Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • AREN 305.8M
  • ABEO 332.0M
  • IPO Year
  • AREN N/A
  • ABEO 1980
  • Fundamental
  • Price
  • AREN $5.90
  • ABEO $6.83
  • Analyst Decision
  • AREN Strong Buy
  • ABEO Strong Buy
  • Analyst Count
  • AREN 1
  • ABEO 6
  • Target Price
  • AREN $12.00
  • ABEO $18.17
  • AVG Volume (30 Days)
  • AREN 243.8K
  • ABEO 702.3K
  • Earning Date
  • AREN 08-14-2025
  • ABEO 08-14-2025
  • Dividend Yield
  • AREN N/A
  • ABEO N/A
  • EPS Growth
  • AREN N/A
  • ABEO N/A
  • EPS
  • AREN 2.74
  • ABEO 0.99
  • Revenue
  • AREN $146,610,000.00
  • ABEO $400,000.00
  • Revenue This Year
  • AREN $29.48
  • ABEO N/A
  • Revenue Next Year
  • AREN $11.72
  • ABEO $339.63
  • P/E Ratio
  • AREN $9.36
  • ABEO $6.91
  • Revenue Growth
  • AREN 6.81
  • ABEO N/A
  • 52 Week Low
  • AREN $0.56
  • ABEO $3.93
  • 52 Week High
  • AREN $10.05
  • ABEO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • AREN 41.23
  • ABEO 52.71
  • Support Level
  • AREN $6.09
  • ABEO $6.70
  • Resistance Level
  • AREN $7.00
  • ABEO $7.15
  • Average True Range (ATR)
  • AREN 0.64
  • ABEO 0.31
  • MACD
  • AREN -0.12
  • ABEO -0.02
  • Stochastic Oscillator
  • AREN 1.52
  • ABEO 46.62

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: